Distinguished in Blepharitis

Lyndon W. Jones

17W Hong Kong Science Park, 
Hong Kong, HCW, HK 
Distinguished in Blepharitis
17W Hong Kong Science Park, 
Hong Kong, HCW, HK 
OverviewLocationsClinical Research

Overview

Lyndon Jones practices in Hong Kong, Hong Kong Special Administrative Region. Mr. Jones is rated as a Distinguished expert by MediFind in the treatment of Blepharitis. His top areas of expertise are Dry Eye Syndrome, Nearsightedness, Blepharitis, and Presbyopia.

His clinical research consists of co-authoring 296 peer reviewed articles and participating in 18 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Blepharitis.

Gender
Male

Locations

17W Hong Kong Science Park, Hong Kong, HCW, Hong Kong Special Administrative Region
Other Locations
Hong Kong Science Park, Hong Kong, HCW, Hong Kong Special Administrative Region

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

18 Clinical Trials

Ocular Effects of Scleral Lens Wear on Dry Eye Patients
Ocular Effects of Scleral Lens Wear on Dry Eye Patients
Enrollment Status: Completed
Publish Date: May 06, 2025
Intervention Type: Device
Study Phase: Not Applicable
The Effect of Xiidra on Comfort and Dryness in Symptomatic Contact Lens Wearers
The Effect of Xiidra on Comfort and Dryness in Symptomatic Contact Lens Wearers
Enrollment Status: Completed
Publish Date: May 04, 2025
Intervention Type: Drug
Study Phase: Phase 4
Efficacy and Safety Study of Novel Spectacle Lens Designs to Control of Myopia
Efficacy and Safety Study of Novel Spectacle Lens Designs to Control of Myopia
Enrollment Status: Active_not_recruiting
Publish Date: December 20, 2024
Intervention Type: Device
Study Phase: Not Applicable
Refitting Daily Disposable Contact Lens Wearers With Dry Eye Disease With A Different Daily Disposable Lens Type
Refitting Daily Disposable Contact Lens Wearers With Dry Eye Disease With A Different Daily Disposable Lens Type
Enrollment Status: Completed
Publish Date: July 25, 2023
Intervention Type: Device
Study Phase: Not Applicable
Investigating iLux Efficacy in Contact Lens Wearers With Evaporative Dry Eye Disease
Investigating iLux Efficacy in Contact Lens Wearers With Evaporative Dry Eye Disease
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Device
Study Phase: Phase 4
Evaluating the Initial Lens Handling Experience of Neophyte Contact Lens Wearers Fitted With Precision1 and 1-Day Acuvue Moist Contact Lenses
Evaluating the Initial Lens Handling Experience of Neophyte Contact Lens Wearers Fitted With Precision1 and 1-Day Acuvue Moist Contact Lenses
Enrollment Status: Completed
Publish Date: February 06, 2023
Intervention Type: Device
Study Phase: Not Applicable
Evaluating the Performance of Precision1 Daily Disposable Contact Lens in a Group of Heavy Digital Device Users
Evaluating the Performance of Precision1 Daily Disposable Contact Lens in a Group of Heavy Digital Device Users
Enrollment Status: Completed
Publish Date: January 26, 2023
Intervention Type: Device
Study Phase: Not Applicable
The Effect of a Novel Blueberry Supplement on Dry Eye Disease (PLUM)
The Effect of a Novel Blueberry Supplement on Dry Eye Disease (PLUM)
Enrollment Status: Completed
Publish Date: January 20, 2023
Intervention Type: Dietary supplement
Study Phase: Phase 3
Comparison of Tear Evaporation Rate With Systane Complete in Dry Eye and Non-Dry Eye
Comparison of Tear Evaporation Rate With Systane Complete in Dry Eye and Non-Dry Eye
Enrollment Status: Completed
Publish Date: June 22, 2022
Intervention Type: Drug
Study Phase: Phase 4
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to PVP-Iodine and Placebo in the Treatment of Adenoviral Conjunctivitis
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to PVP-Iodine and Placebo in the Treatment of Adenoviral Conjunctivitis
Enrollment Status: Terminated
Publish Date: June 14, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to Placebo in the Treatment of Bacterial Conjunctivitis
A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to Placebo in the Treatment of Bacterial Conjunctivitis
Enrollment Status: Completed
Publish Date: June 09, 2021
Intervention Type: Drug
Study Phase: Phase 3
The Use of a Novel Oral Supplement Containing Omega-3 and Omega-6 Fatty Acids on Dry Eye Symptoms (TURMERIC)
The Use of a Novel Oral Supplement Containing Omega-3 and Omega-6 Fatty Acids on Dry Eye Symptoms (TURMERIC)
Enrollment Status: Completed
Publish Date: April 29, 2021
Intervention Type: Dietary supplement
Study Phase: Not Applicable
Comparison of Tear Evaporation Rate With DAILIES TOTAL1 and Biotrue ONEday
Comparison of Tear Evaporation Rate With DAILIES TOTAL1 and Biotrue ONEday
Enrollment Status: Completed
Publish Date: April 23, 2021
Intervention Type: Device
Study Phase: Not Applicable
Bilateral Dispensing Study of MyDay Toric, 1-day Acuvue Moist for Astigmatism, and Dailies Aquacomfort Plus Toric Lenses
Bilateral Dispensing Study of MyDay Toric, 1-day Acuvue Moist for Astigmatism, and Dailies Aquacomfort Plus Toric Lenses
Enrollment Status: Completed
Publish Date: September 12, 2019
Intervention Type: Device
Study Phase: Not Applicable
Performance of Somofilcon A Over One Week in Wearers Adapted to Omafilcon A
Performance of Somofilcon A Over One Week in Wearers Adapted to Omafilcon A
Enrollment Status: Completed
Publish Date: September 12, 2019
Intervention Type: Device
Study Phase: Not Applicable
Comfort Associated With The Use Of Eyelid Cleansing Products Available For The Management Of Demodex Folliculorum
Comfort Associated With The Use Of Eyelid Cleansing Products Available For The Management Of Demodex Folliculorum
Enrollment Status: Completed
Publish Date: July 29, 2019
Intervention Type: Other, Drug
Study Phase: Not Applicable
Clinical Performance Evaluation of Two Silicone Hydrogel Lenses
Clinical Performance Evaluation of Two Silicone Hydrogel Lenses
Enrollment Status: Completed
Publish Date: November 14, 2018
Intervention Type: Device
Study Phase: Not Applicable
The Impact of Hypo-osmolar Drops on Contact Lens Comfort
The Impact of Hypo-osmolar Drops on Contact Lens Comfort
Enrollment Status: Completed
Publish Date: May 04, 2017
Intervention Type: Device
Study Phase: Not Applicable
View 17 Less Clinical Trials

296 Total Publications

TFOS DEWS III.
TFOS DEWS III.
Journal: American journal of ophthalmology
Published: October 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Jones's expertise for a condition
ConditionClose
View All 10 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile